Skip to content
PeptideRank

Every price, read off the source

What a peptide prescription actually costs, checked line by line.

PeptideRank reads every provider's own pricing page and prints what it found — the ongoing rate, not the sign-up rate; the dose the cheap number actually buys; and the pharmacy question most of them decline to answer. Alongside that: 31 free dose calculators, a cited research library, and the comparison tables the rankings are built from. Dated, sourced, and the ranking criteria are printed on the page.

What is on this site

Where to get it

Sermorelin, prescribed properly.

Sermorelin and the GH-secretagogues are not over-the-counter, not safely. We looked at who actually prescribes them, what a compounding pharmacy adds to the price, and which providers hide the real cost until checkout.

74 providers compared

See the ranking

The GLP-1 board

Tirzepatide, ranked on the real monthly cost.

Compounded tirzepatide's advertised price and its true no-commitment monthly cost are not always the same number. We checked every provider's own pricing page, prepay tiers included, before ranking anyone.

137 providers compared

See the ranking

The longevity board

NAD+, sold with no approved drug behind it at all.

Tirzepatide and semaglutide are compounded because an FDA-approved brand is in shortage. NAD+ has no approved drug product to stand in for — every seller compounds it under a pharmacy's general authority, and 10 of the 53 we checked will not name a price before you start an intake.

53 providers compared

See the ranking

PeptideRank, by the numbers

Not marketing copy — counted, live, on this page

  • 181Providers ranked across our boards
  • 649Priced rows, checked against the source
  • 188Full written reviews — no scores, no stars
  • 875Primary sources cited in our research

How a ranking is decided

Disclosure first, price second.

How we earn

Compounded peptide pricing is quoted to be hard to compare: a “from” figure that only applies at the smallest dose, a first-month rate that is not the ongoing one, a pharmacy nobody will name. Of the 189 providers we have checked so far, just 48 states which pharmacy fills its prescriptions and what that pharmacy's FDA category is. That gap is the ranking.

  1. We read the seller's own pageEvery figure on a board came off that company's public pricing page, on a date printed beside it. Not a press release, not another comparison site, not a number a merchant sent us.
  2. Pharmacy disclosure ranks firstA provider that names the pharmacy filling its prescriptions and states that pharmacy's FDA category outranks one that will not — before price is considered at all.
  3. Then, and only then, priceProviders that tie on disclosure are ordered by their own advertised price, low to high. A “starting at” floor is labeled as a floor, never reprinted as if it were a monthly cost.

Free, and free of a signup

Work out the number before you spend anything.

All 31 calculator pages

The reconstitution calculator

Put in the vial strength and the diluent you were given, put in the dose your prescriber wrote down, and read the syringe. It draws the plunger position rather than printing a decimal for you to squint at. It suggests no dose of anything — every number in it is one you supply.

28 molecules, each with its own FDA-status page

Insulin units, converted honestly

There is no fixed “N units = X mg” — it depends entirely on how your vial was mixed. These pages show the arithmetic worked through on labeled hypothetical concentrations instead of handing you a constant that is wrong for most vials.

The same rosters, cheapest first

If price is the only thing you care about, our ranking is in your way. These views take a board's roster and sort it purely on the verified monthly figure — no editorial order applied at all.

The research desk

875 primary sources, each one fetched and checked.

All 124 articles

No citation here was typed from memory. Every PubMed ID is checked against PubMed's own record and every regulatory claim is fetched from the agency's live page before it publishes — which is how we found, and printed, that one compound's advisory committee vote had actually failed and that a paper underpinning another had been retracted. Where the only evidence is in animals, the sentence making the claim says so.

How a source qualifies, and what happens when one is retracted, is written down on our editorial policy.

Open the working, not just the answer

The pricing data, published as a table.

Every provider we track, for every compound it sells, sortable and filterable in one page — not a conclusion about the data, the data itself. Cite it, argue with it, or check a single row against the provider's own site: every figure carries the date it was read and the page it came from.

The cross-board pricing index649 priced rows · 181 providers · 8 boardsThe advertised price, whether the pharmacy filling it is named with an FDA category, and the date we read that price off the seller's own page — every board's rows, unmodified, in one sortable table.Open the pricing index
  • Read off the provider's own page

    Every price here was taken from the company's own public pricing page, on a date we print beside it. Never from a press release, a comparison table, or another site.

  • Silence is a finding

    When a provider will not say what a higher dose costs, or will not name the pharmacy that fills it, we print that instead of estimating around it.

  • Straight about the money

    We say plainly how we are funded: some links here are affiliate links, and a commission may follow. The write-up beside a provider is what should decide it, not the payout.